BeOne Medicines
ONC
#609
Rank
NZ$74.08 B
Marketcap
NZ$654.95
Share price
1.06%
Change (1 day)
14.06%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Quarterly Reports

Thumbnail BeOne Medicines Quarterly Report 2026-q2

Quarterly Report 2026-q2

Language: English

View Quarterly Report
Thumbnail BeOne Medicines Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail BeOne Medicines Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail BeOne Medicines Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report